The 12 closest competitors and alternatives to IdentifAI among biotechnology companies — ranked by similarity to what IdentifAI actually does, not by market-cap band.
Subscribe to see IdentifAI’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Identifai Genetics is a clinical-stage biotechnology and health tech company developing advanced prenatal screening tests using AI, machine learning, and whole genome analysis. It is headquartered in Rosh Haayin, Israel.
IdentifAI is a biotechnology company headquartered in Israel. It has raised at least $8M across the 2 funding rounds on record. Its most recent funding round, Series A, raised $6M in July 2025. Xcout tracks 11 named people at IdentifAI, including Eyal Miller (CEO).
5 more named people on record for IdentifAI, with roles, board committees and tenure — see the full roster →
At least $8M raised across the 2 rounds on record. Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| Series A | $6M | 3 named | |
| Seed | $2.4M | 1 named |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Ranked by semantic similarity — how close each company is to IdentifAI by what it does, using Xcout's live company graph. Click any company for its full profile, or its competitor set.
Biotech
GENinCode Plc specializes in the creation and commercialization of advanced genetic tests designed to forecast potential health risks based on an individual's DNA. Operating in both the United Kingdom and internationally, their predictive technology empowers individuals and medical professionals alike with proactive health management and targeted intervention strategies. The company's sophisticated molecular diagnostics leverage a combination of clinical algorithms and artificial intelligence to deliver precise patient risk assessments, thereby anticipating the onset of various diseases. Among their specialized tests are: Cardio inCode: A patented genetic assay designed to guide individuals in cardiovascular prevention. Lipid inCode: A genetic diagnostic tool that analyzes seven specific genes associated with familial hypercholesterolemia. SUDD inCode: A genetic test to identify the underlying causes of sudden cardiac death and inherited heart conditions. Thrombo inCode: This test assesses 12 genetic variants linked to hereditary thrombophilia and the general risk of thrombosis (blood clots). Thrombo inCode Reproductive Health: Offering crucial insights into thrombophilia risks particularly relevant to prospective pregnancies. Established in 2018, GENinCode Plc maintains its headquarters in Oxford, United Kingdom.
Biotech
GeneDx Holdings Corp., a genomics company, provides genetic testing services. The company primarily offers pediatric and rare disease diagnostics with a focus on whole exome and genome sequencing, as well as data and information services. It also develops an AI-based platform for next generation sequencing analysis, interpretation, and clinical reporting for rare disease, hereditary risk, and cancer testing. GeneDx Holdings Corp. was founded in 2000 and is headquartered in Stamford, Connecticut.
Diagnostics
DELFI Diagnostics is a cancer detection company that utilizes artificial intelligence and whole genome fragmentation analysis to develop blood-based cancer screening tests, such as for lung cancer.
Similar biotechnology company
PhiTech is a TechBio biotechnology company headquartered in Gebze, Kocaeli, Turkey. The firm leads a global shift from DNA-only diagnostics to AI-powered multi-omics, establishing new standards for precision medicine. Utilizing advanced bioinformatics and decision analysis, the company develops cutting-edge diagnostic tools.
Biotechnology & Healthcare
Juno Diagnostics, Inc. operates a laboratory specializing in preimplantation genetic testing for patients undergoing fertility treatments and IVF. The company offers advanced genetic screenings to detect chromosomal abnormalities, single-gene disorders, and structural rearrangements in embryos.
Biotech
Yourgene Health was a UK molecular diagnostics company that developed and commercialized genomic testing technologies, with a focus on reproductive health and non-invasive prenatal testing, including the IONA test. It served clinical laboratories, healthcare providers, and diagnostic partners; the company was acquired by Novacyt in 2023.
Biotech
Gene Solutions LLC provides AI-powered genetic testing and multi-dimensional genomics services focused on oncology and reproductive health. The company offers blood-based early cancer detection tests, tumor profiling, and minimal residual disease monitoring for patients and healthcare providers.
Similar biotechnology company
Base4 Biosciences is a healthcare and AI startup based in Cabrils and Barcelona, Spain, specializing in AI-driven transcriptomic analysis for preventive medicine. The company has raised pre-seed funding to advance its diagnostic and analytical technologies.
Healthcare
Orchid Health, Inc. provides whole-genome embryo screening services for individuals and couples undergoing in vitro fertilization (IVF). The company's testing evaluates embryos for genetic predispositions to thousands of conditions, including cancers, neurodevelopmental disorders, and heart defects, to help patients mitigate hereditary health risks.
Healthcare
Inocras Inc. is a bioinformatics-led biotechnology company headquartered in San Diego, California. The firm utilizes whole genome data and proprietary artificial intelligence analytics to deliver curated genomic care.
Similar biotechnology company
gMendel is a medical technology company founded in 2020 that develops an AI-powered, cloud-based platform combining genomics with artificial intelligence. The company provides decision support software designed to enable faster, more accurate, and scalable diagnosis of genetic disorders.
Biotech
Nevia Bio is an Israel-based biotechnology and health technology company, formerly known as Gina Life, that develops AI-driven diagnostic platforms. The company focuses on creating non-invasive early detection tests for gynecologic cancers, specifically ovarian cancer, by analyzing vaginal fluid.
Search any company we track to see its competitive set.
Paste a short paragraph describing a company or product — we'll find the most similar companies we track, scored 1–100.
Funding, investors, tech stack, hiring signals, leadership and corporate events — for IdentifAIand every competitor above — in one live dashboard.
Subscribe to Xcout Intel →